Meet DelveInsight in BioEurope '16

  • Home Blog Meet delveinsight in bioeurope 16

Meet DelveInsight in BioEurope '16

Nov 02, 2016

p2-n

Downloads

Article in PDF

Recent Articles
  1. Business Cocktail
  2. Introducing a new brand identity, and a new website: DelveInsight.
  3. Indication-Market Insights, Epidemiology and Market Forecast,2010-2020:DelveInsight’s New L...
  4. Notizia
  5. Hematopoietic Stem Cell Transplantation
pharma-news-for-sarepta-imcheck-redhill
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Sarepta Therapeutics Pauses ELEVIDYS Shipments in U.S. After FDA Intervention Over Patient Deaths; ImCheck’s ICT01 Granted FDA Orphan Drug Designation for Acute Myeloid Leukemia; RedHill Biopharma Gets Positive FDA Feedback on RHB-204 for Crohn’s Disease Approval Pathway; FDA Grants Fast Track Designation to ProMIS Neurosciences’ PMN310 for Alzheimer’s Disease; Oruka Therapeutics Receives IND Clearance for Phase IIa Trial of ORKA-001 in Psoriasis

Medical Tourism Trends in 2025_ What’s New and What’s Next feature
Articles

Medical Tourism Trends in 2025: What’s New and What’s Next

pharma-news-for-bayer-klotho-trethera
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Nanoscope’s MCO-010 Begins FDA Rolling Submission for Retinitis Pigmentosa; Bayer’s KERENDIA Approved by FDA for Heart Failure With Preserved Ejection Fraction; Klotho Neurosciences’ KLTO-202 Receives FDA Orphan Drug Designation for ALS; Trethera’s TRE-515 Granted FDA Fast Track Designation for Metastatic Prostate Cancer; Adcentrx’s ADRX-0405 Awarded FDA Orphan Drug Designation for Gastric Cancer

BioEurope
Conference
DelveInsight
loader
loader